CVS Health Corp (NYSE:CVS) shares, rose in value on Friday, January 03, with the stock price up by 0.77% to the previous day’s close as strong demand from buyers drove the stock to $44.56.
Actively observing the price movement in the recent trading, the stock is buoying the session at $44.22, falling within a range of $44.1423 and $45.22. The value of beta (5-year monthly) is 0.543 whereas the PE ratio is 11.32 over 12-month period. Referring to stock’s 52-week performance, its high was $83.25, and the low was $43.56. On the whole, CVS has fluctuated by -24.72% over the past month.
With the market capitalization of CVS Health Corp currently standing at about $56.07 billion, investors are eagerly awaiting this quarter’s results, scheduled for in February. The company’s Forward Dividend Ratio is 2.66, with its dividend yield at 5.97%.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 371.68B, with a low estimate of 94.15B and a high estimate of 98.97B. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 96.96B.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CVS’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0.89, with the price of CVS currently trading nearly -6.54% and -16.27% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 33.04, while the 7-day volatility ratio is showing 2.66% which for the 30-day chart, stands at 3.35%. Furthermore, CVS Health Corp (CVS)’s beta value is 0.58, and its average true range (ATR) is 1.53.
A comparison of CVS Health Corp (CVS) with its peers suggests the former has fared considerably weaker in the market. CVS showed an intraday change of 0.77% in today’s session so far, and over the past year, it shrunk by -44.91%%.
Data on historical trading for CVS Health Corp (NYSE:CVS) indicates that the trading volumes over the past 10 days have averaged 15.23 and over the past 3 months, they’ve averaged 13.56 million. According to company’s latest data on outstanding shares, there are 1.26 billion shares outstanding.
Nearly 0.20% of CVS Health Corp’s shares belong to company insiders and institutional investors own 82.22% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 19.03 million shares as on 2024-12-13, resulting in a short ratio of 1.62. According to the data, the short interest in CVS Health Corp (CVS) stood at 151.00 of shares outstanding as of 2024-12-13; the number of short shares registered in 2024-11-15 reached 21.39 million. The stock has fallen by -0.74% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CVS stock heading into the next quarter.
